当前位置: 首页 > 期刊 > 《中国当代医药》 > 2014年第8期 > 正文
编号:12707032
复合乳酸菌联合三联疗法根除幽门螺杆菌的疗效观察(2)
http://www.100md.com 2014年3月15日 刘爽
第1页

    参见附件。

     [4] Chmiela M,Michetti P.Inflammation,immunity,vaceines for Helicobacter infection[J].Helicobacter,2006,11(Suppl 1):21-26.

    [5] Zou J,Dong J,Yu X.Meta-analysis:Lactobacillus containng quadruple therapy versus standard triple first-line therapy for Helicobacter pylorier adication[J].Helicobacter,2009,14(5):97-107.

    [6] Szajewska H,Horvath A,Piwowarczyk A.Meta-analysis:the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradicationrates and side effects during treatment[J].Aliment Pharmacol Ther,2010,32(9):1069-1079.

    [7] Fujimura S,Watanabe A,Kimura K,et al.Probiotic mechanism of Lactobacillus gasseri OLL2716 strain against Helicobacter pylori[J].J Clin Microbiol,2012,50(3):1134-1136.

    [8] Song MJ,Park DI,Park JH,et al.The effect of probiotics and mucoprotective agents on PPI-based triple therapy for eradication of Helicobacter pylori[J].Helicobacter,2010,15(3):206-213.

    [9] Yasar B,Abut E,Kayadlbl H,et al.Efficacy of probiotics in Helicobacter pylori eradication therapy[J].Turk J Gastroenterol,2010,21(3):212-217.

    (收稿日期:2014-01-17 本文编辑:袁 成)

您现在查看是摘要介绍页,详见PDF附件